You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

List of Excipients in API fingolimod


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing fingolimod

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Novartis Pharmaceuticals Corporation GILENYA fingolimod hcl 0078-0607 FERRIC OXIDE YELLOW
Novartis Pharmaceuticals Corporation GILENYA fingolimod hcl 0078-0607 GELATIN
Novartis Pharmaceuticals Corporation GILENYA fingolimod hcl 0078-0607 MAGNESIUM STEARATE
Novartis Pharmaceuticals Corporation GILENYA fingolimod hcl 0078-0607 MANNITOL
Novartis Pharmaceuticals Corporation GILENYA fingolimod hcl 0078-0607 TITANIUM DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing fingolimod

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc fingolimod 0378-4525 AMMONIA
Mylan Pharmaceuticals Inc fingolimod 0378-4525 DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Mylan Pharmaceuticals Inc fingolimod 0378-4525 FERRIC OXIDE RED
Mylan Pharmaceuticals Inc fingolimod 0378-4525 FERRIC OXIDE YELLOW
Mylan Pharmaceuticals Inc fingolimod 0378-4525 FERROSOFERRIC OXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for fingolimod

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: BETADEX

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: FUMARIC ACID

Excipient focus: GELATIN

Excipient focus: GLYCINE

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POWDERED CELLULOSE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links